Alisha Wainwright

Nutritional psychiatry is still an emerging field.

Ian Campbell told us about plans to expand his team's pilot study into a large-scale randomized control trial, comparing the ketogenic diet with the Eat Well diet recommended by the National Health Service in the UK, and looking at the effect on bipolar symptoms.

and spoke about integrating the experience of patient communities who have already experimented with different diets to help ease their symptoms.

When you think about your field, nutritional psychiatry, where do you see it going in the next five years and perhaps 10 years?

Wolf, it has been an absolute pleasure talking with you today.

Thank you so much for joining me.

Most of us have been bombarded for years with information about what we should and shouldn't eat.

And not all of that information is true or useful.

Nutritional psychiatry is different, a scientific, evidence-backed approach looking at how the food we eat could have an impact on the symptoms of mental health conditions.

Wolf was keen to emphasize that restrictive diets aren't for everyone and that there are more questions to answer and further research is needed.

But there's room for optimism here with the usual disclaimers that under medical guidance and in combination with other treatments, diet could be another effective tool for mental health.

Thanks for listening to this episode of When Science Finds A Way.

Thanks to Dr. Wolfgang Marx and to our contributors, Professor Sherry Johnson and Dr. Ian Campbell.

If you enjoyed this episode, make sure to follow us wherever you get your podcasts and like and subscribe on YouTube.

When Science Finds a Way is brought to you by Wellcome, a charitable foundation that supports the global scientific community, working to build a healthier future for everyone.

To learn more about the work they do, visit their website, welcome.org slash podcast.

That's welcome with two L's.

Discovery doesn't always happen in a straight line.

Sometimes it's a longer path, shaped by who gets listened to and who doesn't.

Tranexamic acid, or TXA, is one of those stories.